uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands
its a late post but just want to see how this end up. i kept an eye on the re-test.. and placed an order at $18.45 after the re-test lets see where this is going.
uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol...
Long-term consolidation has been broken down. The company's financial performance leaves much to be desired. The target levels of the downtrend can be the long-term support levels of 21.85, 4.70.
long in levels and following to target...
NASDAQ: $QURE looks like it's about to SHIT THE BED! #StayAway ...or consider SHORT'ing if shares are available from your Broker! Looks like an EASY WIN!